Dr. Jayaratna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
Fl 6
New York, NY 10029Phone+1 212-659-5559Fax+1 212-987-4675
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2014 - 2016
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 2009 - 2014- University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Surgery, 2008 - 2009
Rutgers New Jersey Medical SchoolClass of 2008
Certifications & Licensure
CA State Medical License 2010 - Present
NY State Medical License 2016 - 2026
TX State Medical License 2015 - 2019- American Board of Urology Urology
Publications & Presentations
PubMed
- 12 citationsAn evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States.Alain Kaldany, Kyle A. Blum, David J. Paulucci, Alp Tuna Beksac, Isuru Jayaratna
Urologic Oncology. 2018-08-01 - 16 citationsEmploying an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, Tiewei Cheng, Jonathan Melquist
Oncotarget. 2017-05-23 - 78 citationsExternal validation of Global Evaluative Assessment of Robotic Skills (GEARS).Monty Aghazadeh, Isuru Jayaratna, Andrew J. Hung, Michael M. Pan, Mihir M. Desai
Surgical Endoscopy. 2015-01-22
Journal Articles
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesIsuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology
Authored Content
- An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018
Research History
- Urologic Oncology Research FellowGenomic research as part of the MD Anderson Bladder Cancer SPORE. Studied bladder cancer molecular subtypes using in vitro and xenograft in vivo models.2014 - 2015
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
